These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 4010851)

  • 21. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients.
    Kanjanabuch T; Puttipittayathorn N; Leelahavanichkul A; Lieusuwan S; Katavetin P; Mahatanan N; Sriudom K; Chirananthavat T; Thongbor N; Eiam-Ong S
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S119-25. PubMed ID: 22043578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis.
    Johnson DW; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Badve SV
    Nephrol Dial Transplant; 2010 Jun; 25(6):1973-9. PubMed ID: 20097847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal sodium mass removal in continuous ambulatory peritoneal dialysis and automated peritoneal dialysis: influence on blood pressure control.
    Ortega O; Gallar P; Carreño A; Gutierrez M; Rodriguez I; Oliet A; Vigil A; Gimenez E
    Am J Nephrol; 2001; 21(3):189-93. PubMed ID: 11423687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endstage renal failure due to polycystic kidney disease managed by continuous ambulatory peritoneal dialysis.
    Graham AN; Neale TJ; Hatfield PJ; Morrison RB; Meech PR; Jacobson A; Faircloth C
    N Z Med J; 1986 Jul; 99(805):491-3. PubMed ID: 3461382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic hypovolemia associated with accelerated hypertension and orthostatic hypotension in a patient on continuous ambulatory peritoneal dialysis.
    Touma T; Muratani H; Iseki K; Kawazoe N; Takishita S; Fukiyama K
    Am J Nephrol; 1992; 12(6):461-5. PubMed ID: 1292347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term continuous ambulatory peritoneal dialysis in diabetics.
    Balaskas EV; Yuan ZY; Gupta A; Meema HE; Blair G; Bargman J; Oreopoulos DG
    Clin Nephrol; 1994 Jul; 42(1):54-62. PubMed ID: 7923968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid function and continuous ambulatory peritoneal dialysis.
    Semple CG; Beastall GH; Henderson IS; Thomson JA; Kennedy AC
    Nephron; 1982; 32(3):249-52. PubMed ID: 7155243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Kidney involvement in scleroderma].
    Ritz E
    Dtsch Med Wochenschr; 1981 Jan; 106(1):23-5. PubMed ID: 7449652
    [No Abstract]   [Full Text] [Related]  

  • 30. Newer modifications of peritoneal dialysis: options in the treatment of patients with renal failure.
    Price CG; Suki WN
    Am J Nephrol; 1981; 1(2):97-104. PubMed ID: 7349048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuous ambulatory peritoneal dialysis (CAPD) in diabetics with end-stage renal disease.
    Amair P; Khanna R; Digenis G; Oreopoulos DG
    Int J Artif Organs; 1982 Mar; 5(2):81-2. PubMed ID: 7047411
    [No Abstract]   [Full Text] [Related]  

  • 32. [Peritoneal dialysis as kidney replacement therapy].
    Gloor HJ
    Schweiz Med Wochenschr; 1989 Aug; 119(31-32):1071-4. PubMed ID: 2678442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous peritoneal dialysis. The first 2 years of a programme at Groote Schuur Hospital.
    Pascoe MD
    S Afr Med J; 1982 Jan; 61(1):19-21. PubMed ID: 7058395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and adequacy of continuous ambulatory peritoneal dialysis.
    Wu G; Kim D; Oreopoulos DG
    Ulster Med J; 1985 Aug; 54 Suppl(Suppl):S48-61. PubMed ID: 3909582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous ambulatory peritoneal dialysis in pediatric patients: a 20-month experience.
    Salusky IB; Kopple JD; Fine RN
    Kidney Int Suppl; 1983 Nov; 15():S101-5. PubMed ID: 6584672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of quality of life in continuous ambulatory peritoneal dialysis and hemodialysis patients].
    Wang T; Liu B; Ye RG
    Zhonghua Nei Ke Za Zhi; 1993 Nov; 32(11):754-6. PubMed ID: 8137656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Continuous ambulatory peritoneal dialysis (CAPD)].
    Mydlík M; Derzsiová K; Válek A; Takác M
    Vnitr Lek; 1982 Jun; 28(6):602-8. PubMed ID: 7112984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.